LRRK2 and cancer: 1. Inhibits oxidation of LDL-C in plasma, platelet aggregation, and inflammation. 2. Antiproliferative, cytotoxic, and inhibitory effects on cancer cell growth. 3. Inhibits mutations in the leucine-rich repeat kinase-2 and uptake of 5-hydroxytryptamine.